Enhancing Corporate Governance and Pharmaceutical Services through Data Analytics and Regulatory Compliance

This paper explores the integral role of corporate governance and regulatory compliance in the pharmaceutical industry, emphasizing how data analytics can strengthen transparency, risk management, and corporate accountability. With a focus on enhancing the safety, efficacy, and accessibility of pharmaceutical services, the paper presents a comprehensive framework for integrating data-driven decision-making into corporate governance structures. The study reviews the impact of global regulatory frameworks and the critical role of regulatory bodies in ensuring drug safety and effectiveness. Additionally, it highlights the significant contributions of pharmacies in achieving universal health coverage (UHC), optimizing operations, and maintaining regulatory standards. Through a review of current practices and challenges, the paper argues that leveraging data analytics in pharmaceutical services can improve operational efficiency, enhance patient outcomes, and foster greater public trust. By offering insights into the regulatory responsibilities of pharmacies and their impact on the healthcare ecosystem, this paper provides a strategic perspective on the future of pharmaceutical governance and service delivery.